Compare ARW & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARW | IRTC |
|---|---|---|
| Founded | 1935 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 4.8B |
| IPO Year | 1994 | 2016 |
| Metric | ARW | IRTC |
|---|---|---|
| Price | $140.36 | $112.49 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $124.33 | ★ $207.54 |
| AVG Volume (30 Days) | 486.8K | ★ 639.6K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 49.93 | ★ 61.71 |
| EPS | ★ 10.93 | N/A |
| Revenue | ★ $30,852,935,000.00 | $747,138,000.00 |
| Revenue This Year | $13.16 | $19.58 |
| Revenue Next Year | $4.51 | $15.95 |
| P/E Ratio | $12.84 | ★ N/A |
| Revenue Growth | 10.49 | ★ 26.24 |
| 52 Week Low | $86.50 | $92.52 |
| 52 Week High | $162.61 | $210.01 |
| Indicator | ARW | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 24.93 |
| Support Level | $120.69 | N/A |
| Resistance Level | $161.62 | $161.36 |
| Average True Range (ATR) | 4.55 | 5.80 |
| MACD | -2.27 | -1.26 |
| Stochastic Oscillator | 24.90 | 2.48 |
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the global components business and the global enterprise computing solutions.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.